干细胞
日本厚生劳动省的一个专家小组已批准将住友制药的Amchepry纳入国家医疗保险覆盖范围，这是一种源自iPS细胞的帕金森病治疗药物。此举使其成为全球首个商业化的iPS细胞医疗产品。
由 AI 报道
A study published on Monday in Nature Microbiology confirms long-term HIV remission in the «Oslo patient», a 62-year-old man treated for myelodysplasia via stem cell transplant from his brother carrying the CCR5 Delta 32 mutation. He has been off antiretrovirals for four years with no detectable virus. This brings the total to ten patients deemed cured this way.